Scientists try to 'Wake Up' tumors to make cancer drug work better

NCT ID NCT05178693

Recruiting now Disease control Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

Summary

This study is testing if taking a pill called ASTX727 for 5 days can make a targeted cancer therapy (Lutathera) more effective for people with advanced neuroendocrine tumors. The pill aims to 'reawaken' a specific target on the tumor cells so the Lutathera treatment can work better. Researchers will use special PET scans to see if the target reappears and monitor how patients respond to the combined treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hammersmith Hospital
RECRUITING

London, London, City of, W12 0HS, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NEUROENDOCRINE TUMORS